2434-56-2

Basic information

• Product Name: 4,6-Diaminopyrimidine
• Synonyms: 4,6-DIAMINOPYRIMIDINE;4,6-PYRIMIDINEDIAMINE;TIMTEC-BB SBB004336;4,6-Pyrimidinediamine (9CI);PYRIMIDINE-4,6-DIAMINE;(6-aminopyrimidin-4-yl)amine;6-PyriMidinediaMine
• CAS NO: 2434-56-2
• Molecular Formula: C₄H₆N₄
• Molecular Weight: 110.12
• Product Categories: PYRIMIDINE;APIs & Intermediate;Amines;Pyrimidines;Nucleic acids;Heterocycle-Pyrimidine series
• Mol File: 2434-56-2.mol
• Article Data: 1

Chemical Properties

• Melting Point: 270-271°C
• Boiling Point: 364 °C at 760 mmHg
• Flash Point: 201.5 °C
• Appearance: yellow to light yellow crystal
• Density: 1.368 g/cm³
• Vapor Pressure: 1.73E-05mmHg at 25°C
• Refractive Index: 1.694
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 5.78±0.10(Predicted)
• CAS DataBase Reference: 4,6-Diaminopyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-Diaminopyrimidine(2434-56-2)
• EPA Substance Registry System: 4,6-Diaminopyrimidine(2434-56-2)

Safety Data

• Hazardous Substances Data: 2434-56-2(Hazardous Substances Data)

Usage

Chemical Properties

Yellow to light yellow crystal

Uses

Different sources of media describe the Uses of 2434-56-2 differently. You can refer to the following data:
1. 4,6-Diaminopyrimidine is a compound used for the preparations of pharmaceutical goods. It was shown that organotin polyamines derived from reaction with 4,6-diaminopyrimidines displayed good inhibitio n of two pancreatic cancer cell lines.
2. 4,6-Diaminopyrimidine is a compound used for the preparations of pharmaceutical goods. It was shown that organotin polyamines derived from reaction with 4,6-diaminopyrimidines displayed good inhibition of two pancreatic cancer cell lines.

InChI:InChI=1/C4H6N4/c5-3-1-4(6)8-2-7-3/h1-2H,(H4,5,6,7,8)

Upstream product

• 1073-99-0 4,5,6-triamino-2-mercapto-pyrimidine 
• 333-49-3 2-thiocytosine 

Downstream Products

• 1193-21-1 4,6-dichloropyrimidine 
• 1334410-01-3 4-(4-(6-aminopyrimidin-4-ylamino)-3H-imidazo[4,5-c]pyridin-2-yl)-3,5-dichlorobenzonitrile 
• 1334409-77-6 N₄-(2-(2,6-dichlorophenyl)-3H-imidazo[4,5-c]pyridin-4-yl)pyrimidine-4,6-diamine 
• 61908-15-4 4,6-diamino-5-nitrosylpyrimidine 
• 1428653-85-3 2-(4-(6-aminopyrimidin-4-ylamino)-3H-imidazo[4,5-c]pyridin-2-yl)-3-fluorobenzonitrile 
• 1229383-37-2 imidazo[1,2-c]pyrimidin-7-ylamine 
• 1354627-40-9 N₄-(8-(2,6-dichlorophenyl)-9-((2-(trimethylsilyl)ethoxy)methyl)-9H-purin-6-yl)pyrimidine-4,6-diamine 
• 908084-16-2 2-phenylimidazo[1,2-c]pyrimidin-7-ylamine 
• 214907-09-2 4,6-diamino-5-iodopyrimidine 
• 128926-49-8 C₁₀H₉BrN₅⁽¹⁵⁾N 
• 102712-36-7 4-(4,6-Diamino-pyrimidin-5-ylazo)-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide 
• 2164-84-3 4,6-Diamino-5-nitropyrimidine 
• 58023-98-6 5-bromo-4,6-diaminopyrimidine 
• 89533-23-3 N-(6-aminopyrimidin-4-yl)acetamide 

Relevant articles and documents

Cephalosporin antibiotics

The present invention relates to a cephalosporin compound represented by the following general formula (I): STR1 its pharmaceutically acceptable non-toxic salt, physiologically hydrolyzable ester, hydrate or solvate, or isomers thereof, in whichR 1 represents hydrogen or an amino-protecting group,R 2 and R 3 can be identical or different and independently of one another represent hydrogen or a hydroxy-protecting group, orR 2 and R 3 together can form a cyclic diol-protecting group,R 4 represents hydrogen or a carboxyl-protecting group,R 5, R 6 and R 7 independently of one another represent hydrogen, amino or substituted amino, hydroxy, alkoxy, C 1-4 alkyl, carboxyl or alkoxycarbonyl, orR 5 and R 6 together with the carbon atoms to which they are attached can form a C 3-7 cycle, andQ represents CH or N,and to a process for preparation thereof and a pharmaceutical composition containing the compound (I) as an active ingredient.